AINewsnow

Why Half of Tracked Drug Launches Still Underperform Pre-Launch Forecasts

This story is from 2026-09-04. It is preserved in the archive; the latest stories are on the live feed.

Launching a new drug is one of the most expensive and high-stakes activities in the pharmaceutical industry. Yet even after years of clinical development, market research, and commercial planning, many launches fail to reach their original revenue expectations. The problem is rarely a single foreca…

Read the full story at DEV Community — AI ↗

Timeline · 1 report

  1. 2026-09-04 06:27 · DEV Community — AI
    Why Half of Tracked Drug Launches Still Underperform Pre-Launch Forecasts

More stories

  1. Google Joins OpenAI, Anthropic, Meta in Disclosing AI Hacks — Bloomberg AI
  2. Anthropic adds support for the AGENTS.md instructions spec to Claude Code; OpenAI contributed AGENTS.md to the Agentic AI Foundation last year (Thomas Claburn/The Register) — Techmeme
  3. Alibaba ships Qwen3.8-Omni-Flash to watch, listen and call tools — r/LocalLLM
  4. Introducing Kimi K3 on Amazon Bedrock — AWS Machine Learning Blog
  5. Introducing Amazon SageMaker HyperPod Inference Gateway — AWS Machine Learning Blog
  6. Introducing Astra for Law — OpenAI News
  7. Newsom signs executive order to explore new AI rules, consider ‘kill switch’ — Politico Technology
  8. Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology

Get the daily brief of stories like this at 6:30 every morning →